v3.25.2
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
OPERATING EXPENSES-        
RESEARCH AND DEVELOPMENT EXPENSES $ 238,612 $ 1,348,985 $ 1,458,921 $ 5,010,618
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES 1,015,733 2,486,846 4,770,181 7,025,503
Total operating expenses 1,254,345 3,835,831 6,229,102 12,036,121
OPERATING LOSS (1,254,345) (3,835,831) (6,229,102) (12,036,121)
OTHER INCOME (EXPENSE), NET        
Interest income 1,409 30,619 17,764 126,872
Interest expense (275,665) (298,248) (2,833,509) (1,038,499)
Loss on debt settlements 0 0 (728,298) 0
Total other expense, net (274,256) (267,629) (3,544,043) (911,627)
LOSS BEFORE INCOME TAXES (1,528,601) (4,103,460) (9,773,145) (12,947,748)
Income tax expense 0 0 0 0
NET LOSS (1,528,601) (4,103,460) (9,773,145) (12,947,748)
Deemed dividends on Series C, D and H Preferred Stock (2,158,161) (100,045) (2,214,375) (262,283)
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS $ (3,686,762) $ (4,203,505) $ (11,987,520) $ (13,210,031)
Basic and diluted loss per share $ (0.55) $ (2.02) $ (2.92) $ (6.42)
Weighted average shares of common stock outstanding- basic and diluted (1) 6,716,252 2,075,972 4,111,922 2,057,873

Source